VAŠKŮ, Anna, Jiří VOKURKA and Julie BIENERTOVÁ VAŠKŮ. Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results. International Journal of Colorectal Disease. Heidelberg, Německo: Springer Verlag, 2008, 15/2008, xx, p. xx, 7 pp. ISSN 0179-1958.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results.
Name in Czech Variabilita v genech spojených s obezitou u českých pacientů se sporadickým kolorektálním karcinomem: předběžné výsledky
Authors VAŠKŮ, Anna (203 Czech Republic, guarantor), Jiří VOKURKA (203 Czech Republic) and Julie BIENERTOVÁ VAŠKŮ (203 Czech Republic).
Edition International Journal of Colorectal Disease, Heidelberg, Německo, Springer Verlag, 2008, 0179-1958.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.767
RIV identification code RIV/00216224:14110/08:00024274
Organization unit Faculty of Medicine
UT WoS 000262986000006
Keywords in English obesity-related genes; colorectal cancer; leptin; leptin receptor
Tags Colorectal cancer, leptin, leptin receptor, obesity-related genes
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Anna Vašků, CSc., učo 122. Changed: 18/6/2009 08:12.
Abstract
BACKGROUND: Genetic variability in obesity-related genes and the resulting phenotypes are being recognized as major risk factors for colorectal cancer and/or severity of the disease. MATERIALS AND METHODS: A total of 102 patients (aged 68 +/- 10.2 years, 79 men and 23 women) and 101 age-matched (68.1 +/- 5.4 years old) individuals without colorectal cancer, 59 men and 42 women, were recruited. All the individuals were genotyped for the following subset of polymorphisms in obesity-related genes: angiotensinogen gene (M235T and -6A/G), in IL-6 gene (-174 G/C and -596 A/G), in leptin gene (-2548 A/G), and polymorphism Gln223Arg within the leptin receptor (LEPR) gene. RESULTS: A significant increase in frequency of double heterozygote genotype (MTAG) of both angiotensinogen polymorphisms in males with colorectal cancer was observed when compared to control men [odds ratio (OR) = 3.77, P (corr) = 0.001]. A marginally significant difference in genotype distribution of -174 G/C IL-6 polymorphism between the patients in stage I-II compared to patients in III-IV was found (P (g) = 0.05, P (a) = 0.173). The GG genotype of -174 G/C IL-6 polymorphism in the patients in stage III-IV carries an increased risk compared to those in stage I-II (OR = 2.83, P (corr) = 0.06). Similarly, a difference in genotype distribution of Gln223Arg in LEPR gene between the patients staged I-II compared to III-IV was observed (P (g) = 0.05). The AA genotype was shown to be risky for the patients staged III-IV (OR = 3.35, P (corr) = 0.06). CONCLUSIONS: The investigated single nucleotide polymorphisms within the genes encoding for obesity-related genes were observed to be associated both with clinical manifestation of colorectal cancer and with severity of the disease. Thus, we suggest that defined genetic variability in the genes might become DNA markers for colorectal cancer in the future.
Abstract (in Czech)
BACKGROUND: Genetic variability in obesity-related genes and the resulting phenotypes are being recognized as major risk factors for colorectal cancer and/or severity of the disease. MATERIALS AND METHODS: A total of 102 patients (aged 68 +/- 10.2 years, 79 men and 23 women) and 101 age-matched (68.1 +/- 5.4 years old) individuals without colorectal cancer, 59 men and 42 women, were recruited. All the individuals were genotyped for the following subset of polymorphisms in obesity-related genes: angiotensinogen gene (M235T and -6A/G), in IL-6 gene (-174 G/C and -596 A/G), in leptin gene (-2548 A/G), and polymorphism Gln223Arg within the leptin receptor (LEPR) gene. RESULTS: A significant increase in frequency of double heterozygote genotype (MTAG) of both angiotensinogen polymorphisms in males with colorectal cancer was observed when compared to control men [odds ratio (OR) = 3.77, P (corr) = 0.001]. A marginally significant difference in genotype distribution of -174 G/C IL-6 polymorphism between the patients in stage I-II compared to patients in III-IV was found (P (g) = 0.05, P (a) = 0.173). The GG genotype of -174 G/C IL-6 polymorphism in the patients in stage III-IV carries an increased risk compared to those in stage I-II (OR = 2.83, P (corr) = 0.06). Similarly, a difference in genotype distribution of Gln223Arg in LEPR gene between the patients staged I-II compared to III-IV was observed (P (g) = 0.05). The AA genotype was shown to be risky for the patients staged III-IV (OR = 3.35, P (corr) = 0.06). CONCLUSIONS: The investigated single nucleotide polymorphisms within the genes encoding for obesity-related genes were observed to be associated both with clinical manifestation of colorectal cancer and with severity of the disease. Thus, we suggest that defined genetic variability in the genes might become DNA markers for colorectal cancer in the future.
Links
KJB501620601, research and development projectName: Funkční analýza rizikového haplotypu RAGE genu a jeho role v patogenezi hyperglykemií indukovaných změn
Investor: Academy of Sciences of the Czech Republic, Functional analysis of the RAGE gene susceptibility haplotype and its role in the hyperglycemia-driven pathology
PrintDisplayed: 13/5/2024 20:55